Neuro42 AI

Neuro42 AI develops MRI and robotics technology for neurology, creating an intraoperative MR imaging system combined with AI and robotic capabilities that allows easy access to MR imaging for screening, diagnosis, and interventions. The company's technology enables point-of-care brain imaging with a portable MRI system designed for use in clinical and surgical settings, supporting real-time imaging during neurosurgical procedures. Neuro42 AI integrates artificial intelligence for image analysis and diagnostic support, enabling neurologists and neurosurgeons to obtain high-quality brain images without transporting patients to traditional MRI suites. The company serves hospitals, neurology clinics, and research institutions. Founded in 2020 and headquartered in San Francisco, California, Neuro42 AI has raised approximately $30 million in Series A funding from investors including Zynext Ventures, ShangBay Capital, HHS, and Kyto Technology & Life Science.